MitoAction
Support, Education, Outreach and Advocacy for Children and Adults Living with Mitochondrial Disease
- This event has passed.
Expert Series: Ultra-Rare Mitochondrial Diseases: Development Challenges and Opportunities
October 6, 2023 @ 12:00 pm – 1:00 pm EDT
Join CEO of Stealth Biotherapeutics Reenie McCarthy, and special guest Shelley Bowen, Director of Family Services and Advocacy for the Barth Syndrome Foundation, as they discuss the health equity challenges faced within the ultra-rare disease space, particularly for mitochondrial targeted therapies, and the potential solutions to overcome these obstacles in therapy development.
About the Speaker
Reenie McCarthy
Reenie McCarthy is the Chief Executive Officer and a member of the Board of Stealth BioTherapeutics. Reenie is a 20+ year veteran of the investment team of Morningside, Stealth’s principal investor, with extensive experience working with private nonclinical and clinical stage companies developing drugs across a broad spectrum of therapeutic areas.
